AU3622600A - Metalloproteinases and methods of use therefor - Google Patents
Metalloproteinases and methods of use thereforInfo
- Publication number
- AU3622600A AU3622600A AU36226/00A AU3622600A AU3622600A AU 3622600 A AU3622600 A AU 3622600A AU 36226/00 A AU36226/00 A AU 36226/00A AU 3622600 A AU3622600 A AU 3622600A AU 3622600 A AU3622600 A AU 3622600A
- Authority
- AU
- Australia
- Prior art keywords
- metalloproteinases
- methods
- use therefor
- therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000005741 Metalloproteases Human genes 0.000 title 1
- 108010006035 Metalloproteases Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26458599A | 1999-03-08 | 1999-03-08 | |
US09264585 | 1999-03-08 | ||
PCT/US2000/006237 WO2000053774A2 (en) | 1999-03-08 | 2000-03-08 | Metalloproteinases and methods of use therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3622600A true AU3622600A (en) | 2000-09-28 |
Family
ID=23006720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36226/00A Abandoned AU3622600A (en) | 1999-03-08 | 2000-03-08 | Metalloproteinases and methods of use therefor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3622600A (en) |
WO (1) | WO2000053774A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7220557B2 (en) | 1997-04-24 | 2007-05-22 | Human Genome Sciences, Inc. | METH1 polynucleotides |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100472L (en) * | 2000-02-18 | 2001-08-19 | Hoffmann La Roche | New metalloproteases having thrombospondome domains and nucleic acid compositions encoding these |
AU2001259473A1 (en) * | 2000-05-04 | 2001-11-12 | Sugen, Inc. | Novel proteases |
WO2002026949A2 (en) * | 2000-09-29 | 2002-04-04 | Lexicon Genetics Incorporated | Human proteases and polynucleotides encoding the same |
AU2001294218A1 (en) * | 2000-10-11 | 2002-04-22 | Kazusa Dna Research Institute Foundation | Novel adamts family polypeptide and gene encoding the same |
WO2002033087A2 (en) * | 2000-10-17 | 2002-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
ES2212695B1 (en) * | 2001-09-14 | 2005-10-16 | Universidad De Oviedo | ADAMTS-13 HUMAN PROTEIN IDENTIFICATION PROCEDURE. |
ES2211256B1 (en) * | 2001-09-28 | 2005-10-16 | Universidad De Oviedo. | ADAMTS-19 HUMAN PROTEIN IDENTIFICATION PROCEDURE. |
ES2205989B1 (en) * | 2001-09-24 | 2005-08-16 | Universidad De Oviedo | ADAMTS-15 HUMAN PROTEIN IDENTIFICATION PROCEDURE. |
ES2201874B1 (en) * | 2001-09-24 | 2005-05-16 | Univesidad De Oviedo | ADAMTS-17 HUMAN PROTEIN IDENTIFICATION PROCEDURE. |
ES2213428B1 (en) * | 2001-09-25 | 2005-11-16 | Universidad De Oviedo. | ADAMTS-19 HUMAN PROTEIN IDENTIFICATION PROCEDURE. |
ES2204250B1 (en) * | 2001-09-24 | 2005-08-16 | Universidad De Oviedo | ADAMTS-16 HUMAN PROTEIN IDENTIFICATION PROCEDURE. |
KR20040088059A (en) | 2002-02-05 | 2004-10-15 | 와이어쓰 | Truncated aggrecanase molecules |
WO2003104390A2 (en) * | 2002-06-06 | 2003-12-18 | The Cleveland Clinic Foundation | Adamts nucleic acids and proteins |
CA2492444A1 (en) | 2002-07-29 | 2004-02-05 | Wyeth | Modified adamts4 molecules and method of use thereof |
US7696307B2 (en) * | 2004-04-12 | 2010-04-13 | The Trustees Of The University Of Pennsylvania | Function and regulation of ADAMTS-1 |
EP2305811A1 (en) * | 2005-07-27 | 2011-04-06 | Oncotherapy Science, Inc. | Method of diagnosing smal cell lung cancer |
EP2171450B1 (en) * | 2007-06-22 | 2012-03-21 | GENERA ISTRAZIVANJA d.o.o. | Adamts4 as a blood biomarker and therapeutic target for chronic renal failure |
PT2650310T (en) | 2012-04-13 | 2016-09-01 | Rottapharm Biotech Srl | Anti-adamts-5 antibody, derivatives and uses thereof |
WO2015110707A1 (en) * | 2014-01-24 | 2015-07-30 | University Of Helsinki | Methods and uses related to adamts3 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69822307T2 (en) * | 1997-06-03 | 2005-02-17 | Kureha Chemical Industry Co., Ltd. | HUMAN ADAMTS-1 PROTEIN, GENE, WHICH CODES FOR THIS, PHARMACEUTICAL COMPOSITION AND METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF HUMAN ADAMTS-1 PROTEINS |
-
2000
- 2000-03-08 WO PCT/US2000/006237 patent/WO2000053774A2/en active Application Filing
- 2000-03-08 AU AU36226/00A patent/AU3622600A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7220557B2 (en) | 1997-04-24 | 2007-05-22 | Human Genome Sciences, Inc. | METH1 polynucleotides |
Also Published As
Publication number | Publication date |
---|---|
WO2000053774A2 (en) | 2000-09-14 |
WO2000053774A3 (en) | 2001-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
AU2468401A (en) | Underreamer and method of use | |
AU3867400A (en) | Methods of using bioelastomers | |
AU7339800A (en) | Ophthalmic device and method of manufacture and use | |
AU2466099A (en) | Pharmaceutically active compounds and methods of use thereof | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU5013100A (en) | Maize rs81 promoter and methods of use thereof | |
AU3622600A (en) | Metalloproteinases and methods of use therefor | |
AU2002314466A1 (en) | Withasol and methods of use | |
AU6340600A (en) | Telomerase inhibitors and methods of their use | |
AU4717301A (en) | Catheter assembly and method of use | |
AU715620C (en) | Therapeutic methods and uses | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU5886500A (en) | Indolyl-benzimidazole antibacterials, and methods of use thereof | |
AU4848200A (en) | Intravascular device and methods of manufacture and use | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
AU3501700A (en) | Human endokine alpha and methods of use | |
AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
AU2003279800A1 (en) | Sulfatases and methods of use thereof | |
AU3725500A (en) | Hand-held bidet and method of use | |
AU3863900A (en) | Prolyl peptidases and methods of use | |
AU4021700A (en) | Methods of use of beta1-integrin inhibitors | |
AUPQ760400A0 (en) | Herbical formulations and methods of use thereof | |
AU3078101A (en) | Micromolds fabricated using mems technology and methods of use therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |